Alpha-synuclein: normal function and role in neurodegenerative diseases
- PMID: 15094295
- DOI: 10.1016/S0070-2153(04)60002-0
Alpha-synuclein: normal function and role in neurodegenerative diseases
Abstract
Synucleins are a family of small, highly charged proteins expressed predominantly in neurons. Since their discovery and characterization during the last decade, much has been learned about their structure, potential functions, interactions with other proteins, and roles in disease. One of these proteins, alpha-synuclein (alpha-syn), is the major building block of pathological inclusions that characterize many neurodegenerative disorders, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and neurodegeneration with brain iron accumulation type 1 (NBIA-1), which collectively are termed synucleinopathies. Furthermore, genetic and biological studies support a role for alpha-syn in the pathophysiology of these diseases. Therefore, research must be continued in order to better understand the functions of the synuclein proteins under normal physiological conditions as well as their role in diseases.
Similar articles
-
Alpha-synuclein and neurodegenerative diseases.Nat Rev Neurosci. 2001 Jul;2(7):492-501. doi: 10.1038/35081564. Nat Rev Neurosci. 2001. PMID: 11433374 Review. No abstract available.
-
alpha-Synuclein is phosphorylated in synucleinopathy lesions.Nat Cell Biol. 2002 Feb;4(2):160-4. doi: 10.1038/ncb748. Nat Cell Biol. 2002. PMID: 11813001
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
-
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.
-
The role of alpha-synuclein in neurodegenerative diseases.Pharmacol Ther. 2005 Mar;105(3):311-31. doi: 10.1016/j.pharmthera.2004.10.010. Epub 2004 Dec 8. Pharmacol Ther. 2005. PMID: 15737408 Review.
Cited by
-
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.Sci Rep. 2018 Aug 20;8(1):12462. doi: 10.1038/s41598-018-30808-9. Sci Rep. 2018. PMID: 30127535 Free PMC article.
-
Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.J Biol Chem. 2011 Oct 7;286(40):34690-9. doi: 10.1074/jbc.M111.261321. Epub 2011 Aug 10. J Biol Chem. 2011. PMID: 21832061 Free PMC article.
-
Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders.Brain Pathol. 2019 Jul;29(4):544-557. doi: 10.1111/bpa.12697. Epub 2019 Jan 29. Brain Pathol. 2019. PMID: 30582885 Free PMC article.
-
The pathobiological basis of depression in Parkinson disease: challenges and outlooks.J Neural Transm (Vienna). 2022 Dec;129(12):1397-1418. doi: 10.1007/s00702-022-02559-5. Epub 2022 Nov 2. J Neural Transm (Vienna). 2022. PMID: 36322206 Free PMC article. Review.
-
Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.Parkinsons Dis. 2017;2017:9164754. doi: 10.1155/2017/9164754. Epub 2017 Nov 23. Parkinsons Dis. 2017. PMID: 29333317 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous